Bahija Jallal (Source: MedImmune)
Woodford who? TCR-focused Immunocore soldiers on with $130M+ B round
Immunocore — once a darling of the now-disgraced Neil Woodford — is shaking off its past by raising more than $130 million in a Series B haul …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
